Analyst Ratings for Savient Pharmaceuticals (SVNT)
SVNT Rating Summary
SVNT Price Target Summary
- Highest: $2.00 (Canaccord Genuity)
- Lowest: $1.00 (Jefferies)
- Average: $1.38
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$1.38 (+83.3%)
Avg. $ Target:
$1.38 (+83.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/17/2013 | William Blair | Downgrade | Market Perform (Outperform) |
1.00 (2.00) |
0.57 | 0.75 | 31.58% | Details |
| 3/26/2012 | Canaccord Genuity | New Coverage | Hold (N/A) |
2.00 (N/A) |
2.13 | 0.75 | -64.79% | Details |
| 2/1/2012 | Cowen | Downgrade | Neutral (N/A) |
N/A (N/A) |
2.53 | 0.75 | -70.36% | Details |
| 11/10/2011 | JMP Securities | Downgrade | Market Underperform (N/A) |
1.50 (N/A) |
2.98 | 0.75 | -74.83% | Details |
| 7/14/2011 | Leerink Swann | Upgrade | Market Perform (N/A) |
N/A (N/A) |
7.39 | 0.75 | -89.85% | Details |
| 5/20/2011 | Citadel Securities » Updated 6/22/2011 |
Downgrade | Neutral (N/A) |
N/A (N/A) |
8.12 | 0.75 | -90.76% | Details |
| 5/9/2011 | Lazard Capital | Downgrade | Hold (N/A) |
N/A (N/A) |
8.83 | 0.75 | -91.51% | Details |
| 5/6/2011 | JPMorgan | Downgrade | Neutral (N/A) |
N/A (N/A) |
8.57 | 0.75 | -91.25% | Details |
| 4/11/2011 | Wedbush | New Coverage | Outperform (N/A) |
N/A (N/A) |
10.42 | 0.75 | -92.8% | Details |
| 4/7/2011 | Mizuho Securities | New Coverage | Buy (N/A) |
N/A (N/A) |
10.59 | 0.75 | -92.92% | Details |
| 11/8/2010 | Soleil Securities | Upgrade | Buy (N/A) |
N/A (N/A) |
11.73 | 0.75 | -93.61% | Details |
| 9/16/2010 | Oppenheimer | Downgrade | Perform (N/A) |
N/A (N/A) |
19.98 | 0.75 | -96.25% | Details |
| 8/5/2010 | BofA/Merrill Lynch | Upgrade | Neutral (N/A) |
N/A (N/A) |
14.24 | 0.75 | -94.73% | Details |
